Xtant Medical Holdings, Inc. Common Stock — Cash Flow (NYSE:XTNT)

Financials

Cash from operating activities -731 K439 K-5.34 M-9.52 M-11.9 M12.55 M 9.15 M Cash from investing activities -1.3 M-1.89 M-1.56 M-24.78 M-3.73 M7.9 M 19.26 M Cash from financing activities -861 K17.5 M9.02 M19.69 M16.07 M-9.57 M -21.93 M Free cash flow -731 K439 K-5.34 M-9.52 M-11.9 M10.16 M 7.77 M

News

Xtant Medical at 2026 CG Musculoskeletal Conference: Strategic Shift to Regenerative Biologics

Xtant Medical receives $10.7M payment from Companion Spine

Xtant Medical launches next-generation synthetic bone graft

Companion Spine acquires Paradigm Spine from Xtant Medical

Xtant Medical completes sale of Coflex assets for $19.2 million

Xtant Medical stock price target lowered to $1.50 by BTIG on Q3 results

Xtant Medical earnings beat by $0.02, revenue topped estimates

Xtant Medical shareholders approve board nominees and expand equity plan

Xtant Medical launches CollagenX for surgical wound closure

Xtant Medical at H.C. Wainwright: Strategic Growth and Market Expansion

Xtant Medical Holdings, Inc. (XTNT) Q2 2025 Earnings Call Transcript

Xtant Medical earnings beat by $0.03, revenue topped estimates